Improvement in major depression after low subcutaneous doses of MIF-1
- 1 August 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Affective Disorders
- Vol. 31 (4) , 227-233
- https://doi.org/10.1016/0165-0327(94)90098-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: Comparison with morphinePeptides, 1994
- Evidence for presence of Tyr‐MIF‐1 (Tyr‐Pro‐Leu‐Gly‐NH2) in human brain cortexInternational Journal of Peptide and Protein Research, 1990
- Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1Life Sciences, 1986
- Antagonism of morphine analgesia by prolyl-leucyl-glycinamide (MIF-1) in humansPharmacology Biochemistry and Behavior, 1984
- Similar antagonism of morphine analgesia by MIF-1 and naloxone in Carassius auratusPharmacology Biochemistry and Behavior, 1982
- Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depressionAmerican Journal of Psychiatry, 1978
- MIF, TRH, and simian social and motor behaviorPharmacology Biochemistry and Behavior, 1976
- Intensification of central catecholaminergic and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin IIPharmacology Biochemistry and Behavior, 1975
- Melanocyte-Stimulating Hormone-Release Inhibiting Hormone as an AntidepressantArchives of General Psychiatry, 1974
- Effect of Melanocyte-Stimulating Hormone-Release Inhibiting Factor (MIF) in Parkinson’s SyndromEuropean Neurology, 1974